ACD/Labs Integrates ChemSketch to Chmoogle Search Engine
News Nov 23, 2005
Chmoogle® is an open-access chemistry search engine with the mission to discover, curate, and index all of the public chemical information in the world, and make it available to the public for free.
Chmoogle distinguishes itself by extremely fast searches, an appealing presentation of results, high-quality chemical drawings, and advanced search capabilities like persistent hitlists and hitlist logic operations.
This integration gives ChemSketch users direct access to Chmoogle’s structure and substructure searches.
"The world's knowledge in chemistry is an invaluable resource," said Dr. Klaus Gubernator, eMolecule's Chief Executive Officer.
"It lies dormant until it becomes searchable by every chemist. The language of chemistry is chemical structures."
"Chmoogle makes the world's chemistry searchable by structure. Just draw a molecule using your favorite structure drawing tool and hit Go!"
"We are very intrigued by the clever integration of structure drawing and searching in Chmoogle that ACD/Labs is providing and we are even more excited about the fact that it is free for chemists around the world."
Antony Williams, VP and Chief Science Officer for ACD/Labs, furthers, "The mission of Chmoogle to discover, curate, and index all public chemical information in the world and make it available for free is a worthy mission."
"The intention of ACD/Labs to provide a chemical structure drawing package to every chemist in the world at no charge via our freeware ChemSketch downloads is just as worthy."
"We are happy to provide an integrated solution between ChemSketch and Chmoogle to allow users to sketch molecules at their desktop and view their results via a Web browser."
"It is our hope that sketching and Chmoogling will deliver value to chemists around the world!"
Tuberculosis (TB), an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and the antibiotics that have been used to fight the disease in recent history are becoming less and less effective. In the face of this reality, researcher Prof. Dennis Wright has improved upon a new way to thwart the tricky pathogen, mycobacterium tuberculosis.READ MORE
Researchers have solved the structures of the cancer-promoting enzymes USP25 and USP28, and identified significant differences in their activities. This knowledge provides the molecular basis for the development of new and highly specific anti-cancer drugs, with a low risk of side-effects.READ MORE